After passing the necessary clinical tests by Russian authorities, the first batch of the coronavirus vaccine was put into circulation
| 09/07/2020 | ionicons-v5-c23: 20 | Web Writing |
Moscow.- The Russian Ministry of Health announced on Tuesday (local time) that the first batch of the vaccine Sputnik V, which will serve to combat Covid-19, has already been put into circulation among the population, after passing the necessary quality tests.
According to the deputy director of the Clinical Department of the Gamaleya Center, Denis LogunovAfter passing clinical trials, the vaccine showed « a very good safety profile. »
The official indicated that during the investigations no serious side effects were reported and « 100 percent of the volunteers developed neutralizing antibodies to the virus. »
Health Authorities in Russia reported that « in the near future », the delivery of the first batches of the dose to the regions of the country is expected.
The Lancet publishes Phase I and II trial results
The scientific journal The Lancet has published the results of the Phase I and II clinical trials of the vaccine Sputnik V, which was announced on August 11 by Russian authorities.
In the post, the vaccine’s developers indicate that 100 percent of the participants developed a stable cellular and humoral immune response during the process.
Likewise, the levels of antibodies against the virus in vaccinated volunteers were 1.4 to 1.5 times higher than the level of antibodies developed by patients who recovered from Covid-19.